Related Experiment Video

Updated: May 28, 2026

Electrophoretic Delivery of γ-aminobutyric Acid (GABA) into Epileptic Focus Prevents Seizures in Mice
07:01

Electrophoretic Delivery of γ-aminobutyric Acid (GABA) into Epileptic Focus Prevents Seizures in Mice

Published on: May 16, 2019

Antiepleptic drug interactions: a clinical case demonstration

Hundie Tesfaye1, Eva Klapková, Alena Tesfayeová

  • 1Department of Clinical Biochemistry and Pathobiochemistry, Division of Clinical Pharmacology, University Hospital, Motol, Czech Republic. hundie.tesfaye@fnmotol.cz

Casopis Lekaru Ceskych
|October 27, 2011
PubMed

Insights

This case study highlights how common antiepileptic drugs can interact, worsening refractory epilepsy in a young patient. Careful medication review is crucial for managing drug interactions in epilepsy treatment.

Area of Science:

  • Neurology
  • Pharmacology
  • Clinical Medicine

Background:

  • Epilepsy affects millions globally, often managed with antiepileptic drugs (AEDs).
  • Identifying epilepsy aetiology can be challenging, leading to empiric treatment strategies.
  • AEDs are essential for seizure control but carry risks of adverse drug interactions.

Observation:

  • A 15-year-old female presented with refractory epilepsy and focal cortical dysplasia (FCD).
  • The patient experienced seizure deterioration despite standard AED treatment.
  • Her medication regimen included valproic acid, phenobarbital (or primidone), and carbamazepine.

Findings:

  • The seizure worsening was strongly suspected to be linked to drug-drug interactions among her prescribed AEDs.
  • Specific interactions between valproic acid, phenobarbital/primidone, and carbamazepine are known to affect AED efficacy and levels.
  • Children and adolescents may exhibit unique adverse events and sensitivities to these interactions.

Implications:

  • This case underscores the critical need for vigilant monitoring of AEDs in paediatric epilepsy.
  • Understanding potential drug-drug interactions is vital for optimizing treatment and preventing seizure exacerbation.
  • Personalized medication management is essential for patients with refractory epilepsy, especially in pediatric cases.

More Related Videos

Non-restraining EEG Radiotelemetry: Epidural and Deep Intracerebral Stereotaxic EEG Electrode Placement06:58

Non-restraining EEG Radiotelemetry: Epidural and Deep Intracerebral Stereotaxic EEG Electrode Placement

Published on: June 25, 2016

Related Concept Videos

Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
Antiepileptic Drugs: Sodium Channel Blockers01:08

Antiepileptic Drugs: Sodium Channel Blockers

Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
Pharmacokinetics: Drug–Drug Interactions01:25

Pharmacokinetics: Drug–Drug Interactions

Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
Antiepileptic Drugs: Calcium Channel Blockers01:17

Antiepileptic Drugs: Calcium Channel Blockers

Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...